Aether Bio

[Not Yet Scheduled]
Aether is building the post-scarcity future by developing the most advanced enzyme engineering platform to date. By treating protein engineering as a search problem, we are pushing the boundaries of what’s possible in biocatalysis, and revolutionizing the way molecules are made.
We’ve built proprietary robotics and state-of-the-art deep learning algorithms to drive massively parallelized experimentation, enabling us to search through trillions of enzyme designs and find a viable match for almost any chemical process. Aether’s technology integrates into existing production pipelines, dramatically reduces manufacturing costs, is sustainable, and minimizes time to market for new products.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
2017
Main Therapeutic Focus:
Lead Product in Development:
anti-viral precursor
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
3
Speaker
photo
CEO
Aether Biomachines, Inc.